N-(t-Butoxycarbonyl)-2-(3-phenylpropyl)-L-proline
  1. Home
  2. Amino Acids
  3. BOC-Amino Acids
  4. N-(t-Butoxycarbonyl)-2-(3-phenylpropyl)-L-proline
Need Assistance?
  • US & Canada:
    +1-844-BOC(262)-0123
  • UK: +44-20-3286-1088

N-(t-Butoxycarbonyl)-2-(3-phenylpropyl)-L-proline

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
BOC-Amino Acids
Catalog number
BAT-004397
CAS number
1217837-34-7
Molecular Formula
C19H27NO4
Molecular Weight
333.42
N-(t-Butoxycarbonyl)-2-(3-phenylpropyl)-L-proline
IUPAC Name
(2R)-1-[(2-methylpropan-2-yl)oxycarbonyl]-2-(3-phenylpropyl)pyrrolidine-2-carboxylic acid
Synonyms
Boc-(3-Phenylpropyl)Pro-OH; Boc-(R)-α-(3-phenylpropyl)-proline; (R)-1-(t-Butoxycarbonyl)-2-(3-phenylpropyl)pyrrolidine-2-carboxylic acid; (2R)-1-[(2-methylpropan-2-yl)oxycarbonyl]-2-(3-phenylpropyl)pyrrolidine-2-carboxylic acid
Purity
≥ 95%
InChI
InChI=1S/C19H27NO4/c1-18(2,3)24-17(23)20-14-8-13-19(20,16(21)22)12-7-11-15-9-5-4-6-10-15/h4-6,9-10H,7-8,11-14H2,1-3H3,(H,21,22)/t19-/m1/s1
InChI Key
ZMZPCACRGQMUGK-LJQANCHMSA-N
Canonical SMILES
CC(C)(C)OC(=O)N1CCCC1(CCCC2=CC=CC=C2)C(=O)O
Related Products
Matrixyl 3000
Matrixyl 3000

CAT NO. : BAT-006226
NFAT Inhibitor
NFAT Inhibitor

CAT NO. : BAT-006191
GIP (human)
GIP (human)

CAT NO. : BAT-006165
Cibinetide
Cibinetide

CAT NO. : BAT-009111
Acetyl tetrapeptide-15
Acetyl tetrapeptide-15

CAT NO. : BAT-006221
Pasireotide acetate
Pasireotide acetate

CAT NO. : BAT-016459
Matrixyl 3000
Matrixyl 3000

CAT NO. : BAT-006226
NFAT Inhibitor
NFAT Inhibitor

CAT NO. : BAT-006191
GIP (human)
GIP (human)

CAT NO. : BAT-006165
Cibinetide
Cibinetide

CAT NO. : BAT-009111
Acetyl tetrapeptide-15
Acetyl tetrapeptide-15

CAT NO. : BAT-006221
Pasireotide acetate
Pasireotide acetate

CAT NO. : BAT-016459
Online Inquiry
0
Inquiry Basket

No data available, please add!

Delete selectedGo to checkout

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

x